WHO ICTRP trial
Study on Assessing Severity of Hypervirulent Pneumonia through Early Blood Test
ChiCTR2500113285 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113285 |
|---|---|
| Public title | Study on Assessing Severity of Hypervirulent Pneumonia through Early Blood Test |
| Scientific title | Prospective Cohort Study on the Proportion of Early Peripheral Blood Polymorphonuclear Myeloid-Derived Suppressor Cells in Risk Assessment for Severe Progression in Patients with Hypervirulent Klebsiella pneumoniae Infection |
| Primary sponsor | Shanghai General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | fever, altered mental status, abdominal pain, chest pain, myalgia |
| Interventions | Case group (severe):NA;Case group (non-severe):None |
| Registration date | Nov 26, 2025 |
| Target size | Case group (severe):60;Case group (non-severe):60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: